help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumaki, F.
Right arrow Articles by Ferrans, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumaki, F.
Right arrow Articles by Ferrans, V. J.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 187-191, (2002)
© 2002 American Thoracic Society


Brief Communication

Expression of Human Telomerase Reverse Transcriptase in Lymphangioleiomyomatosis

Fumiyuki Kumaki, Kazuyo Takeda, Zu-Xi Yu, Joel Moss and Victor J. Ferrans

Pathology Section and Pulmonary Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland

Correspondence and requests for reprints should be addressed to Zu-Xi Yu, M.D., Ph.D., Pathology Section, National Heart, Lung, and Blood Institute, Building 10/2N240, National Institutes of Health, 10 Center Drive MSC-1518, Bethesda, MD 20892-1518. E-mail: yuz{at}helix.nih.gov

Telomerase synthesizes nucleotide hexameric repeats (telomeres) at the ends of chromosomes, replacing base sequences that are lost from these sites during each mitotic cycle and protecting these ends against the action of exonucleases and ligases. Therefore, telomerase is essential for maintaining cellular replication. To evaluate the role of telomerase in the proliferation of abnormal smooth muscle cells (lymphangioleiomyomatosis [LAM] cells) in LAM, we performed immunostaining and in situ hybridization studies to identify telomerase protein and messenger RNA (mRNA), respectively, in pulmonary (n = 18) and extrapulmonary (n = 4) lesions from 22 women with LAM (14 untreated and 8 treated with progesterone or tamoxifen). Immunoreactivity and hybridization signals for telomerase were observed in 5 to 20% of LAM cells, mostly of the spindle-shaped type, in 21 of the 22 patients, and were less intense in the treated group. Other types of cells were unreactive in both groups. Telomerase colocalized in the same cells with {alpha}-smooth muscle actin, but only rarely with HMB-45 antibody (a marker for epithelioid LAM cells); colocalization with proliferating cell nuclear antigen was incomplete. The telomerase-positive LAM cells may constitute the sources of renewal of LAM cells. Modulation of telomerase may be involved in the control of LAM cell proliferation.

Key Words: lymphangioleiomyomatosis • lung • telomerase • smooth muscle cells




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. E. Sietsema and F. X. McCormack
Lymphangioleiomyomatosis: Insights about, and from, a Rare Disease
Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1405 - 1406.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society
  New Orleans Int'l Conf